WallStreetZenWallStreetZen

NYSE: QGEN
Qiagen Nv Stock

$43.20-0.29 (-0.67%)
Updated Feb 28, 2024
QGEN Price
$43.20
Fair Value Price
N/A
Market Cap
$9.86B
52 Week Low
$35.81
52 Week High
$49.18
P/E
29.19x
P/B
2.59x
P/S
5.25x
PEG
1.13x
Dividend Yield
2.96%
Revenue
$1.97B
Earnings
$341.30M
Gross Margin
62.8%
Operating Margin
24.59%
Profit Margin
17.4%
Debt to Equity
0.61
Operating Cash Flow
$459M
Beta
0.42
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

QGEN Overview

Qiagen N.V. offers molecular diagnostics, applied testing, academic and pharmaceutical research. Specific offerings include nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies. It also offers secondary sample technology consumable (kits and components for purification of nucleic acids, instruments for nucleic acid purification, and accessories). Qiagen N.V was founded in 1986 and is headquartered in Venlo, the Netherlands.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how QGEN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

QGEN ($43.20) is trading above its intrinsic value of $21.50, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
QGEN is good value based on its earnings relative to its share price (29.19x), compared to the US market average (35.52x)
P/E vs Market Valuation
QGEN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more QGEN due diligence checks available for Premium users.

Be the first to know about important QGEN news, forecast changes, insider trades & much more!

QGEN News

Valuation

QGEN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
29.19x
Industry
40.18x
Market
35.52x
QGEN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
QGEN is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

QGEN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.59x
Industry
4.33x
QGEN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

QGEN price to earnings growth (PEG)

For valuing profitable companies with growth potential
QGEN is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

QGEN's financial health

Profit margin

Revenue
$509.2M
Net Income
$97.7M
Profit Margin
19.2%
QGEN's Earnings (EBIT) of $483.22M... subscribe to Premium to read more.
Interest Coverage Financials
QGEN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$6.1B
Liabilities
$2.3B
Debt to equity
0.61
QGEN's short-term assets ($2.15B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
QGEN's short-term assets ($2.15B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
QGEN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
QGEN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$151.4M
Investing
-$58.5M
Financing
-$7.4M
QGEN's operating cash flow ($459.46M)... subscribe to Premium to read more.
Debt Coverage Financials

QGEN vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
QGEN$9.86B-0.67%29.19x2.59x
EXAS$10.22B-1.04%-49.83x3.25x
NTRA$9.20B+0.51%-16.94x11.72x
MEDP$12.40B-0.11%43.82x22.18x
CRL$13.18B+1.49%27.69x3.67x

Qiagen Nv Stock FAQ

What is Qiagen Nv's quote symbol?

(NYSE: QGEN) Qiagen Nv trades on the NYSE under the ticker symbol QGEN. Qiagen Nv stock quotes can also be displayed as NYSE: QGEN.

If you're new to stock investing, here's how to buy Qiagen Nv stock.

What is the 52 week high and low for Qiagen Nv (NYSE: QGEN)?

(NYSE: QGEN) Qiagen Nv's 52-week high was $49.18, and its 52-week low was $35.81. It is currently -12.15% from its 52-week high and 20.62% from its 52-week low.

How much is Qiagen Nv stock worth today?

(NYSE: QGEN) Qiagen Nv currently has 228,202,755 outstanding shares. With Qiagen Nv stock trading at $43.20 per share, the total value of Qiagen Nv stock (market capitalization) is $9.86B.

Qiagen Nv stock was originally listed at a price of $5.97 in Dec 31, 1997. If you had invested in Qiagen Nv stock at $5.97, your return over the last 26 years would have been 623.5%, for an annualized return of 7.91% (not including any dividends or dividend reinvestments).

How much is Qiagen Nv's stock price per share?

(NYSE: QGEN) Qiagen Nv stock price per share is $43.20 today (as of Feb 28, 2024).

What is Qiagen Nv's Market Cap?

(NYSE: QGEN) Qiagen Nv's market cap is $9.86B, as of Feb 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Qiagen Nv's market cap is calculated by multiplying QGEN's current stock price of $43.20 by QGEN's total outstanding shares of 228,202,755.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.